Salute e Benessere
Notice of 2015 Annual General Meeting in CellaVision AB
The shareholders in CellaVision AB are hereby summoned to the Annual General Meeting, to be held on May 6, 2015 at 16.00 at CellaVision AB, Scheelevägen 19 A, Ideon, in Lund, Sweden.
The complete notice is available in Swedish only.
For more information, please contact: Zlatko Rihter, CEO, CellaVision AB
Phone: +46 733 62 11 06 | E-mail:
zlatko.rihter@cellavision.com
About CellaVision CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses, for example of infections and serious cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In 2014 sales were SEK 217 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund and the company has subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at
www.cellavision.com
Copyright GlobeNewswire
Attachment(s)
http://hugin.info/132164/R/1908393/680071.pdf
Regulatory News
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: %s via Globenewswire